Affiliation:
1. University of Alberta, Division of Otolaryngology – Head and Neck Surgery University of Alberta Hospital Edmonton Alberta Canada
Abstract
AbstractBackgroundTo help ensure adequate hemostasis immediately following potassium titanyl phosphate (KTP) laser treatment, many centres treating hereditary hemorrhagic telangiectasia (HHT) routinely use nasal packing post‐operatively. The purpose of this study was to compare hemostatic thrombin matrix with standard packing for postoperative bleeding, patient pain, and comfort.MethodsA prospective, randomized, double‐blinded, non‐inferiority study was conducted with participants at an HHT centre of excellence (COE) and randomized to the treatment group with reconstituted thrombin gelatin matrix (Surgiflo®) or control group with a biodegradable synthetic polyurethane foam (NasoPore®). Adult subjects with confirmed HHT and moderate to severe epistaxis (a minimum calculated epistaxis severity score [ESS] of 4.0) warranting KTP laser treatment were recruited. Data was collected 2 weeks post operatively by a blinded reviewer completing a visual outcomes evaluation and each patient completing a subjective symptoms questionnaire. Non‐parametric statistical analysis was employed.ResultsTwenty‐eight adult patients were randomized to the treatment and control arms with comparable preoperative epistaxis severity scores. Postoperative nasal bleeding was equivalent. Significantly less pain was found in the treatment arm (p = .005). While there were trends towards less obstruction and increased satisfaction in the treatment group as well as less crusting in the control group, these findings were not statistically significant. Allocation to the treatment group was associated with an approximately $75 higher cost.ConclusionsWhen compared to NasoPore® for hemostasis, Surgiflo® hemostatic matrix performed equivalently while causing less discomfort in HHT patients following nasal KTP treatment.Level of evidence1b.
Reference36 articles.
1. Update on Clinical Strategies in Hereditary Hemorrhagic Telangiectasia from an ENT Point
of View
2. ShovlinC. (2022)Clinical manifestations and diagnosis of hereditary hemorrhagic telangiectasia (Osler‐Weber‐Rendu syndrome).UpToDate. Retrieved September 5 2022 from:www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-hereditary-hemorrhagic-telangiectasia-osler-weber-rendu-syndrome.
3. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia
4. Investigation of the presence of HPV on KTP laser fibers following KTP laser treatment of papilloma
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献